Patients at High risk | Patients at Low-risk | p-values | |
---|---|---|---|
n | 43 | 33 | |
male gender | 28 | 20 | 0.50 |
Age | 57 ± 14 | 61 ± 10 | 0.29 |
CMR parameters | |||
EF (%) | 57 ± 4 | 62 ± 10 | 0.09 |
EDM (g) | 195 ± 58 | 181 ± 76 | 0.36 |
EDV (ml) | 156 ± 53 | 139 ± 42 | 0.14 |
ESV (ml) | 67 ± 32 | 54 ± 28 | 0.07 |
SV (ml) | 88 ± 30 | 84 ± 28 | 0.58 |
LVEDD (mm) | 50 ± 7 | 49 ± 7 | 0.54 |
SWT (mm) | 20 ± 5 | 17 ± 4 | 0.004 |
PWT (mm) | 10 ± 3 | 10 ± 2 | 0.91 |
RVEDD (mm) | 43 ± 6 | 42 ± 7 | 0.42 |
RVESD (mm) | 28 ± 6 | 28 ± 7 | 0.76 |
Presence of LGE | 29/43 (67%) | 14/33 (47%) | 0.03 |
% of LV mass with LGE | 14% | 3% | 0.001 |
Clinical characteristics | |||
Dyspnea | 11 | 4 | 0.14 |
Chest pain | 13 | 5 | 0.12 |
Atrial fibrillation | 18 | 3 | 0.26 |
HCM with obstruction | 25 | 10 | 0.06 |
Diabetes | 4 | 5 | 0.35 |
Hypertension | 25 | 19 | 0.49 |
Hyperlipidemia | 10 | 13 | 0.13 |